ID   SERPH_HUMAN             Reviewed;         418 AA.
AC   P50454; B3KVJ3; P29043; Q5XPB4; Q6NSJ6; Q8IY96; Q9NP88;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   07-APR-2021, entry version 210.
DE   RecName: Full=Serpin H1;
DE   AltName: Full=47 kDa heat shock protein;
DE   AltName: Full=Arsenic-transactivated protein 3;
DE            Short=AsTP3;
DE   AltName: Full=Cell proliferation-inducing gene 14 protein;
DE   AltName: Full=Collagen-binding protein;
DE            Short=Colligin;
DE   AltName: Full=Rheumatoid arthritis-related antigen RA-A47;
DE   Flags: Precursor;
GN   Name=SERPINH1; Synonyms=CBP1, CBP2, HSP47, SERPINH2; ORFNames=PIG14;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fibroblast;
RX   PubMed=1309665; DOI=10.1016/0167-4781(92)90498-o;
RA   Clarke E., Sandwal B.D.;
RT   "Cloning of a human collagen-binding protein, and its homology with rat
RT   gp46, chick hsp47 and mouse J6 proteins.";
RL   Biochim. Biophys. Acta 1129:246-248(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7656593; DOI=10.1159/000134103;
RA   Ikegawa S., Sudo K., Okui K., Nakamura Y.;
RT   "Isolation, characterization and chromosomal assignment of human colligin-2
RT   gene (CBP2).";
RL   Cytogenet. Cell Genet. 71:182-186(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cartilage, and Fibroblast;
RX   PubMed=11052465; DOI=10.1007/s007740070004;
RA   Hattori T., Takahash K., Yutani Y., Fujisawa T., Nakanishi T., Takigawa M.;
RT   "Rheumatoid arthritis-related antigen 47kDa (RA-A47) is a product of
RT   colligin-2 and acts as a human HSP47.";
RL   J. Bone Miner. Metab. 18:328-334(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wu S.-H., Cheng J., Zheng Y.-J., Zhang Y.-X., Liu Y., Zhong Y.-W.;
RT   "Cloning and identification of human AsTP3 gene transactivated by arsenic
RT   trioxide in HepG2 cells.";
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kim J.W.;
RT   "Identification of a human cell proliferation gene 14.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Ovary, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   POLYMORPHISM IN PROMOTER, AND INVOLVEMENT IN PPROM.
RX   PubMed=16938879; DOI=10.1073/pnas.0603676103;
RA   Wang H., Parry S., Macones G., Sammel M.D., Kuivaniemi H., Tromp G.,
RA   Argyropoulos G., Halder I., Shriver M.D., Romero R., Strauss J.F. III;
RT   "A functional SNP in the promoter of the SERPINH1 gene increases risk of
RT   preterm premature rupture of membranes in African Americans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:13463-13467(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S., Fischer-Posovszky P.,
RA   Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANT OI10 PRO-78.
RX   PubMed=20188343; DOI=10.1016/j.ajhg.2010.01.034;
RA   Christiansen H.E., Schwarze U., Pyott S.M., AlSwaid A., Al Balwi M.,
RA   Alrasheed S., Pepin M.G., Weis M.A., Eyre D.R., Byers P.H.;
RT   "Homozygosity for a missense mutation in SERPINH1, which encodes the
RT   collagen chaperone protein HSP47, results in severe recessive osteogenesis
RT   imperfecta.";
RL   Am. J. Hum. Genet. 86:389-398(2010).
CC   -!- FUNCTION: Binds specifically to collagen. Could be involved as a
CC       chaperone in the biosynthetic pathway of collagen.
CC   -!- INTERACTION:
CC       P50454; P54819: AK2; NbExp=3; IntAct=EBI-350723, EBI-1056291;
CC       P50454; Q9NP61: ARFGAP3; NbExp=3; IntAct=EBI-350723, EBI-2875816;
CC       P50454; P54253: ATXN1; NbExp=3; IntAct=EBI-350723, EBI-930964;
CC       P50454; P54252: ATXN3; NbExp=3; IntAct=EBI-350723, EBI-946046;
CC       P50454; Q8TBE0: BAHD1; NbExp=3; IntAct=EBI-350723, EBI-742750;
CC       P50454; P12830: CDH1; NbExp=3; IntAct=EBI-350723, EBI-727477;
CC       P50454; Q8NE08: COL25A1; NbExp=3; IntAct=EBI-350723, EBI-25836642;
CC       P50454; P48730-2: CSNK1D; NbExp=3; IntAct=EBI-350723, EBI-9087876;
CC       P50454; P49184: DNASE1L1; NbExp=3; IntAct=EBI-350723, EBI-20894690;
CC       P50454; P15036: ETS2; NbExp=3; IntAct=EBI-350723, EBI-1646991;
CC       P50454; Q969W3: FAM104A; NbExp=3; IntAct=EBI-350723, EBI-10281506;
CC       P50454; O75874: IDH1; NbExp=3; IntAct=EBI-350723, EBI-715695;
CC       P50454; Q6PI98: INO80C; NbExp=3; IntAct=EBI-350723, EBI-722540;
CC       P50454; P06756: ITGAV; NbExp=3; IntAct=EBI-350723, EBI-298282;
CC       P50454; P23276: KEL; NbExp=3; IntAct=EBI-350723, EBI-746662;
CC       P50454; O60259: KLK8; NbExp=3; IntAct=EBI-350723, EBI-3915857;
CC       P50454; Q9NPC7: MYNN; NbExp=3; IntAct=EBI-350723, EBI-3446748;
CC       P50454; Q16549: PCSK7; NbExp=3; IntAct=EBI-350723, EBI-8059854;
CC       P50454; Q9NUD9: PIGV; NbExp=3; IntAct=EBI-350723, EBI-25836582;
CC       P50454; Q8TBJ4: PLPPR1; NbExp=3; IntAct=EBI-350723, EBI-18063495;
CC       P50454; Q13200: PSMD2; NbExp=4; IntAct=EBI-350723, EBI-357648;
CC       P50454; P21246: PTN; NbExp=3; IntAct=EBI-350723, EBI-473725;
CC       P50454; Q13702-2: RAPSN; NbExp=3; IntAct=EBI-350723, EBI-22012855;
CC       P50454; Q6NTF9-3: RHBDD2; NbExp=3; IntAct=EBI-350723, EBI-17589229;
CC       P50454; P61513: RPL37A; NbExp=3; IntAct=EBI-350723, EBI-356793;
CC       P50454; Q8NC51: SERBP1; NbExp=3; IntAct=EBI-350723, EBI-523558;
CC       P50454; Q16586: SGCA; NbExp=3; IntAct=EBI-350723, EBI-5663553;
CC       P50454; Q99720-4: SIGMAR1; NbExp=3; IntAct=EBI-350723, EBI-25831036;
CC       P50454; Q8NCS7: SLC44A5; NbExp=3; IntAct=EBI-350723, EBI-21504521;
CC       P50454; Q16560-2: SNRNP35; NbExp=3; IntAct=EBI-350723, EBI-12938570;
CC       P50454; Q7Z614-3: SNX20; NbExp=3; IntAct=EBI-350723, EBI-12336127;
CC       P50454; O43463: SUV39H1; NbExp=3; IntAct=EBI-350723, EBI-349968;
CC       P50454; P25490: YY1; NbExp=3; IntAct=EBI-350723, EBI-765538;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen.
CC   -!- INDUCTION: By heat shock.
CC   -!- POLYMORPHISM: A functional SNP in the promoter of SERPINH1 is
CC       associated in African Americans with an increased risk for preterm
CC       premature rupture of membranes (PPROM) [MIM:610504]. PPROM is defined
CC       as rupture of the membranes before 37 weeks of gestation. SERPINH1 with
CC       the -656 T allele displays significantly reduced promoter activity
CC       compared to the major -656 C allele. Prematurity is correlated with an
CC       increased frequency of the -656 T allele.
CC   -!- DISEASE: Osteogenesis imperfecta 10 (OI10) [MIM:613848]: A form of
CC       osteogenesis imperfecta, a connective tissue disorder characterized by
CC       low bone mass, bone fragility and susceptibility to fractures after
CC       minimal trauma. Disease severity ranges from very mild forms without
CC       fractures to intrauterine fractures and perinatal lethality.
CC       Extraskeletal manifestations, which affect a variable number of
CC       patients, are dentinogenesis imperfecta, hearing loss, and blue
CC       sclerae. OI10 is an autosomal recessive form characterized by multiple
CC       bone deformities and fractures, generalized osteopenia, dentinogenesis
CC       imperfecta, and blue sclerae. {ECO:0000269|PubMed:20188343}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the serpin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Osteogenesis imperfecta variant database;
CC       Note=Serpin H1 (SERPINH1);
CC       URL="http://oi.gene.le.ac.uk/home.php?select_db=SERPINH1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X61598; CAA43795.1; -; mRNA.
DR   EMBL; D83174; BAA11829.1; -; mRNA.
DR   EMBL; AB044778; BAA96788.1; -; mRNA.
DR   EMBL; AB044779; BAA96789.1; -; mRNA.
DR   EMBL; AY744367; AAU95378.1; -; mRNA.
DR   EMBL; AY264853; AAP93914.1; -; mRNA.
DR   EMBL; BT007094; AAP35758.1; -; mRNA.
DR   EMBL; AK122936; BAG53805.1; -; mRNA.
DR   EMBL; CH471076; EAW74974.1; -; Genomic_DNA.
DR   EMBL; BC014623; AAH14623.1; -; mRNA.
DR   EMBL; BC036298; AAH36298.2; -; mRNA.
DR   EMBL; BC070087; AAH70087.1; -; mRNA.
DR   CCDS; CCDS8239.1; -.
DR   PIR; I52968; I52968.
DR   PIR; S20608; S20608.
DR   RefSeq; NP_001193943.1; NM_001207014.1.
DR   RefSeq; NP_001226.2; NM_001235.3.
DR   RefSeq; XP_011543629.1; XM_011545327.1.
DR   SMR; P50454; -.
DR   BioGRID; 107318; 178.
DR   IntAct; P50454; 107.
DR   MINT; P50454; -.
DR   STRING; 9606.ENSP00000434412; -.
DR   BindingDB; P50454; -.
DR   ChEMBL; CHEMBL5286; -.
DR   MEROPS; I04.035; -.
DR   GlyConnect; 658; 26 N-Linked glycans (2 sites).
DR   GlyGen; P50454; 2 sites, 4 N-linked glycans (2 sites).
DR   iPTMnet; P50454; -.
DR   MetOSite; P50454; -.
DR   PhosphoSitePlus; P50454; -.
DR   SwissPalm; P50454; -.
DR   BioMuta; SERPINH1; -.
DR   DMDM; 20141241; -.
DR   DOSAC-COBS-2DPAGE; P50454; -.
DR   UCD-2DPAGE; P50454; -.
DR   CPTAC; CPTAC-272; -.
DR   CPTAC; CPTAC-273; -.
DR   EPD; P50454; -.
DR   jPOST; P50454; -.
DR   MassIVE; P50454; -.
DR   MaxQB; P50454; -.
DR   PaxDb; P50454; -.
DR   PeptideAtlas; P50454; -.
DR   PRIDE; P50454; -.
DR   ProteomicsDB; 56229; -.
DR   TopDownProteomics; P50454; -.
DR   Antibodypedia; 3838; 517 antibodies.
DR   DNASU; 871; -.
DR   Ensembl; ENST00000358171; ENSP00000350894; ENSG00000149257.
DR   Ensembl; ENST00000524558; ENSP00000434412; ENSG00000149257.
DR   Ensembl; ENST00000533603; ENSP00000434657; ENSG00000149257.
DR   GeneID; 871; -.
DR   KEGG; hsa:871; -.
DR   UCSC; uc001owr.4; human.
DR   CTD; 871; -.
DR   DisGeNET; 871; -.
DR   GeneCards; SERPINH1; -.
DR   HGNC; HGNC:1546; SERPINH1.
DR   HPA; ENSG00000149257; Tissue enhanced (vagina).
DR   MalaCards; SERPINH1; -.
DR   MIM; 600943; gene.
DR   MIM; 610504; phenotype.
DR   MIM; 613848; phenotype.
DR   neXtProt; NX_P50454; -.
DR   OpenTargets; ENSG00000149257; -.
DR   Orphanet; 216812; Osteogenesis imperfecta type 3.
DR   PharmGKB; PA35034; -.
DR   VEuPathDB; HostDB:ENSG00000149257.13; -.
DR   eggNOG; KOG2392; Eukaryota.
DR   GeneTree; ENSGT00940000156163; -.
DR   HOGENOM; CLU_023330_2_0_1; -.
DR   InParanoid; P50454; -.
DR   OMA; NMPLGQK; -.
DR   OrthoDB; 1124079at2759; -.
DR   PhylomeDB; P50454; -.
DR   TreeFam; TF343094; -.
DR   PathwayCommons; P50454; -.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   BioGRID-ORCS; 871; 7 hits in 1001 CRISPR screens.
DR   ChiTaRS; SERPINH1; human.
DR   GeneWiki; Heat_shock_protein_47; -.
DR   GenomeRNAi; 871; -.
DR   Pharos; P50454; Tbio.
DR   PRO; PR:P50454; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P50454; protein.
DR   Bgee; ENSG00000149257; Expressed in stromal cell of endometrium and 226 other tissues.
DR   ExpressionAtlas; P50454; baseline and differential.
DR   Genevisible; P50454; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005518; F:collagen binding; NAS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:GO_Central.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:Ensembl.
DR   GO; GO:0003433; P:chondrocyte development involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0032964; P:collagen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0030199; P:collagen fibril organization; IBA:GO_Central.
DR   GO; GO:0010951; P:negative regulation of endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0051604; P:protein maturation; IEA:Ensembl.
DR   GO; GO:0006986; P:response to unfolded protein; TAS:ProtInc.
DR   CDD; cd02046; serpinH1_CBP1; 1.
DR   Gene3D; 2.30.39.10; -; 1.
DR   Gene3D; 3.30.497.10; -; 1.
DR   InterPro; IPR023795; Serpin_CS.
DR   InterPro; IPR023796; Serpin_dom.
DR   InterPro; IPR000215; Serpin_fam.
DR   InterPro; IPR033830; Serpin_H1_serpin_dom.
DR   InterPro; IPR036186; Serpin_sf.
DR   InterPro; IPR042178; Serpin_sf_1.
DR   InterPro; IPR042185; Serpin_sf_2.
DR   InterPro; IPR033547; SERPINH1.
DR   PANTHER; PTHR11461; PTHR11461; 1.
DR   PANTHER; PTHR11461:SF27; PTHR11461:SF27; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; SSF56574; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chaperone; Endoplasmic reticulum; Glycoprotein;
KW   Osteogenesis imperfecta; Phosphoprotein; Reference proteome; Signal;
KW   Stress response.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..418
FT                   /note="Serpin H1"
FT                   /id="PRO_0000032520"
FT   MOTIF           415..418
FT                   /note="Prevents secretion from ER"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10138"
FT   COMPBIAS        25..29
FT                   /note="Poly-Ala"
FT   SITE            377..378
FT                   /note="Reactive bond homolog"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         94
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19324"
FT   MOD_RES         141
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         207
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19324"
FT   MOD_RES         296
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19324"
FT   MOD_RES         319
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19324"
FT   CARBOHYD        120
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        125
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         41
FT                   /note="A -> P (in dbSNP:rs7105528)"
FT                   /id="VAR_028445"
FT   VARIANT         78
FT                   /note="L -> P (in OI10; dbSNP:rs137853892)"
FT                   /evidence="ECO:0000269|PubMed:20188343"
FT                   /id="VAR_063602"
FT   CONFLICT        7..10
FT                   /note="LSAF -> GTL (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        14..15
FT                   /note="EA -> AV (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        25..26
FT                   /note="AA -> VE (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        38
FT                   /note="P -> S (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        41
FT                   /note="A -> T (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        46..48
FT                   /note="RSA -> PST (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        164
FT                   /note="R -> P (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        168..169
FT                   /note="SA -> RP (in Ref. 2; BAA11829)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        235
FT                   /note="M -> T (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        255
FT                   /note="I -> L (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        270
FT                   /note="L -> F (in Ref. 9; AAH70087)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        409
FT                   /note="P -> L (in Ref. 1; CAA43795)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   418 AA;  46441 MW;  B7719FCA13A55DEB CRC64;
     MRSLLLLSAF CLLEAALAAE VKKPAAAAAP GTAEKLSPKA ATLAERSAGL AFSLYQAMAK
     DQAVENILVS PVVVASSLGL VSLGGKATTA SQAKAVLSAE QLRDEEVHAG LGELLRSLSN
     STARNVTWKL GSRLYGPSSV SFADDFVRSS KQHYNCEHSK INFRDKRSAL QSINEWAAQT
     TDGKLPEVTK DVERTDGALL VNAMFFKPHW DEKFHHKMVD NRGFMVTRSY TVGVMMMHRT
     GLYNYYDDEK EKLQIVEMPL AHKLSSLIIL MPHHVEPLER LEKLLTKEQL KIWMGKMQKK
     AVAISLPKGV VEVTHDLQKH LAGLGLTEAI DKNKADLSRM SGKKDLYLAS VFHATAFELD
     TDGNPFDQDI YGREELRSPK LFYADHPFIF LVRDTQSGSL LFIGRLVRPK GDKMRDEL
//
